Research output per year
Research output per year
Organisation profile
Organisation profile
Immunology, the science of how the body protects itself against infection and cancer, and immunotherapy, the treatment of disease through the manipulation of the immune system, are arguably the most exciting areas of medicine at the current time. Such approaches promise the opportunity of controlling infectious diseases while providing more effective cures for diseases including cancer, common autoimmune disorders and allergies and Alzheimer’s disease.
Birmingham has a very strong history of immunology research going back 30 years, and with one of the greatest concentrations of scientists and doctors in the world is well positioned to make a world-leading contribution.
Our research spans many aspects of the immune system, from the formation of white cells within the thymus gland (a small gland in the neck) to clinical trials on patients with diseases such as cancer, multiple sclerosis or viral infections.
Our key research strengths include:
- Immunology
- Cancer Immunology
- Virology
- Liver Disease
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Immunology and Immunotherapy is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
An economic evaluation of Direct Oral Penicillin Challenge for De-labelling Low Risk Patients with a Penicillin Allergy Label
Bestwick, R., Bhogal, R., Kildonaviciute, K., Ng, B. Y., Jackson, B., Moriarty, C., Thomas, C., Savic, L., Misbah, S. A., T. Krishna, M. & Muijica-Mota, R., 5 Feb 2025, (E-pub ahead of print) In: Clinical and Experimental Allergy .Research output: Contribution to journal › Article › peer-review
Open AccessFile -
A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer
Middleton, G., Robbins, H. L., Fletcher, P., Savage, J., Mehmi, M., Summers, Y., Greystoke, A., Steele, N., Popat, S., Jain, P., Spicer, J., Cave, J., Shaw, P., Gilligan, D., Power, D., Fennell, D., Bajracharya, M., Mcbride, D. J., Maheswari, U. & Frankell, A. M. & 3 others, , 11 Mar 2025, In: npj Precision Oncology. 9, 1, 11 p., 67.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms
Greenman, R. & Weston, C. J., 13 Jan 2025, In: Cells. 14, 2, 16 p., 105.Research output: Contribution to journal › Review article › peer-review
Open AccessFile
-
KRUK CRTF Investigating how Altered Metabolic Pathways and Immune Responses affect the Control of Infection in Chronic Kidney Disease
Sturman, J. (Principal Investigator)
1/03/25 → 29/02/28
Project: Research
-
Thrombo-STOP: Apixaban thromboprophylaxis to prevent venous thromboembolism in ambulatory lung cancer patients undergoing systemic anticancer treatment
Jowett, S. (Co-Investigator), Billingham, L. (Co-Investigator), Ignatowicz, A. (Co-Investigator), Newnham, M. (Principal Investigator), Turner, A. (Co-Investigator), Pirrie, S. (Co-Investigator) & Middleton, G. (Co-Investigator)
1/03/25 → 28/02/30
Project: Other Government Departments
-
BRC CF8: Therapeutic optimisation of dendritic cell function in oesophageal adenocarcinoma
Moss, P. (Principal Investigator)
1/02/25 → 31/01/26
Project: Other Government Departments
Activities
-
AWEX visit: ATMPS
Grover, L. (Host), Iqbal, T. (Invited speaker), El Haj, A. (Speaker), Metcalfe, T. (Host), Taylor, G. (Speaker) & Cunningham, A. (Speaker)
3 Oct 2024Activity: Academic and Industrial events › Conference, workshop or symposium
-
HTI Visit: Peter Kyle, Shadow Secretary for DSIT, Richard Parker, Labour Candididate for West Midlands Mayor
El Haj, A. (Advisor), Grover, L. (Advisor), Wall, I. (Advisor), Mendes, P. (Advisor) & Williams, R. (Advisor)
11 Jan 2024Activity: Engagement and Public events › Engagement event
-
Innovative Therapies for Children with Cancer Annual Meeting
Mussai, F. (Advisor)
8 Nov 2018Activity: Academic and Industrial events › Conference, workshop or symposium
Datasets
-
Perfusate Proteins Detected during Normothermic Machine Perfusion of Discarded Human Livers.
Stephenson, B. (Creator), Afford, S. (Creator) & Wallace, L. (Creator), University of Birmingham, 2019
DOI: 10.25500/edata.bham.00000361
Dataset
-
Cell Surface Proteomics of Cholangiocarcinoma Cell Line (CC-SW-1)
Stephenson, B. (Creator), Afford, S. (Creator) & Martin, A. (Creator), University of Birmingham, 2019
DOI: 10.25500/edata.bham.00000362
Dataset
-
Supporting data for the PhD thesis "Dissecting the role of VAP-1 in innate immune cell responses in the establishment and progression of liver disease"
Rink, M. (Creator), Weston, C. (Creator) & Horn, P. (Creator), University of Birmingham, Feb 2022
DOI: 10.25500/edata.bham.00000776
Dataset
Prizes
-
ACR/EULAR Academic Exchange Fellowship
Raza, K. (Recipient), 2006
Prize: Fellowship awarded competitively
-
Arthritis Research UK Foundation Fellowship
Bending, D. (Recipient), 2011
Prize: Fellowship awarded competitively
-
Best International Abstract
Jones, N. (Recipient), 18 May 2000
Prize: Prize (including medals and awards)
Press/Media
-
Birmingham scientists 're-train' immune system to prevent attack of healthy cells in new UK study into autoimmune diseases
9/06/20 → 15/06/20
2 Media contributions
Press/Media: Press / Media
-
Interview regarding on paediatric/ immunology research
Mussai, F.
1/06/16
1 Media contribution
Press/Media: Press / Media
-